Newsroom

Press Releases

August 5, 2025

CancerVax Successfully Disguises Cancer Cells and Tricks Immune Cells into Attacking Them

CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform designed to use the body’s immune system to treat cancer, today announced that it has proven a major foundational hypothesis

June 19, 2025

CancerVax Nanoparticle Successfully Targets Cancer Cells While Sparing Non-cancerous Cells

CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform designed to use the body’s immune system to treat cancer, today announced that its ligand conjugated lipid nanoparticle (“LNP”) successfully targeted cancer cells and avoided non-cancerous cells

June 9, 2025

CancerVax Targets Liver Cancers to Further Showcase Flexibility of Its Universal Platform

CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform designed to use the body’s immune system to treat cancer, today announced that it will expand its preclinical program to include liver cancers, specifically rare stem cell-like forms of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC). Patients with these stem cell-like tumors have a significantly worse survival than patients with more traditional liver tumors

June 5, 2025

CancerVax Achieves Major Milestone with Successful Creation of Cell Targeting Nanoparticle

CancerVax, Inc., the developer of a breakthrough universal cancer treatment (UCT) platform designed to use the body’s immune system to treat cancer, today announced the successful creation of its nanoparticle that can target specific cells that are potentially cancerous

News Commentary

Thumbnail

- July 10, 2025 - CancerVax News Commentary

Thumbnail

- May 12, 2025 - CancerVax News Commentary

Thumbnail

- January 13, 2025 - CancerVax News Commentary